Given that Spike A222V and Spike S943N arose in both p5 and p10 of cells expressing animal ACE2, we posited that these mutations may confer an adaptive advantage for SARS-CoV-2 through infection via animal ACE2. The gene discussed is CHMP5; the disease is infection.